Skip to content
Evigrade
CriticalClass III antiarrhythmic×Fourth-generation fluoroquinolone

Updated · Methodology

Mechanism

Dronedarone, a class III antiarrhythmic, moderately prolongs the heart-rate-corrected QT interval (QTc). According to the European SmPC, the increase is about 10 ms (Bazett). The US label estimates 15 ms at 400 mg twice daily with food, and the effect grows with concentration (dronedarone summary of product characteristics, SmPC, European Medicines Agency, EMA, and label, US Food and Drug Administration, FDA). Moxifloxacin itself prolongs the QTc in some people. The prolongation may increase with higher plasma concentrations, including with fast intravenous infusion (moxifloxacin SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, and FDA label). According to the Spanish moxifloxacin SmPC, an additive effect on the QT interval with other QT-prolonging drugs cannot be excluded. Such an effect may increase the risk of ventricular arrhythmias, including torsade de pointes (moxifloxacin SmPC, AEMPS). The documents describe no pharmacokinetic interaction for this pair. For moxifloxacin, interactions through cytochrome P450 enzymes are unlikely (moxifloxacin SmPC, AEMPS).

Symptoms

QT prolongation itself causes no symptoms and shows only on an electrocardiogram (ECG). The adverse reactions of moxifloxacin include palpitations, ventricular tachyarrhythmias, fainting, torsade de pointes and cardiac arrest. Women and older people may be more sensitive to QT-prolonging drugs (moxifloxacin summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The adverse reactions of dronedarone include a slow heart rate and prolongation of the heart-rate-corrected QT interval (QTc). Dronedarone has a low proarrhythmic effect, but arrhythmias can occur when it is combined with drugs that favour arrhythmias or when electrolytes are disturbed (dronedarone SmPC, European Medicines Agency, EMA).

Management

The combination is contraindicated. The Spanish moxifloxacin summaries of product characteristics (SmPCs) contraindicate moxifloxacin with other drugs that prolong the QT interval and name class III antiarrhythmics separately. According to its own SmPC, dronedarone belongs to this class and itself prolongs the QT interval (moxifloxacin SmPCs, Spanish Agency of Medicines and Medical Devices, AEMPS; dronedarone SmPC, European Medicines Agency, EMA). The dronedarone documents in turn contraindicate dronedarone with drugs that prolong the QT interval and can induce torsade de pointes. Moxifloxacin is not among their examples. The contraindication still covers it, because the moxifloxacin documents describe QT prolongation and torsade de pointes (dronedarone SmPC, EMA, and label, US Food and Drug Administration, FDA; moxifloxacin SmPC, AEMPS). The US moxifloxacin label says to avoid moxifloxacin in people taking class IA or class III antiarrhythmics (moxifloxacin FDA label). Moxifloxacin is also contraindicated in documented congenital or acquired QT prolongation, electrolyte disturbances (especially uncorrected low potassium), a clinically relevant slow heart rate, clinically relevant heart failure with reduced left ventricular ejection fraction and a history of symptomatic arrhythmias (moxifloxacin SmPC, AEMPS). Dronedarone is contraindicated in current or past heart failure, a heart rate below 50 beats per minute and a Bazett-corrected QT interval (QTc) of 500 ms or more. If any contraindication arises during treatment, stop dronedarone (dronedarone SmPC, EMA). Correct potassium and magnesium deficiency before and during dronedarone treatment. During treatment, the SmPC recommends monitoring that includes an electrocardiogram (ECG). Stop dronedarone if the QTc reaches 500 ms or more (dronedarone SmPC, EMA). No document gives an interval between stopping one drug and starting the other. Dronedarone and its metabolite are fully cleared from plasma 2 weeks after dronedarone is stopped. The mean elimination half-life of moxifloxacin is about 12 hours (dronedarone SmPC, EMA; moxifloxacin SmPC, AEMPS).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Dronedarone

Other interactions with Moxifloxacin